|
141 |
Comparative Efficacy of IL-12/23 and IL-23 Inhibitors for Induction and Maintenance Therapy in Moderate-to-Severe Crohn’s Disease: A Systematic Review and Network Meta-Analysis
Enthalten in Inflammatory intestinal diseases Bd. 10, 2025, Nr. 1: 265-284. 20 S.
|
|
|
|
142 |
Full-spectrum extract from Cannabis sativa DKJ127 for chronic low back pain: a phase 3 randomized placebo-controlled trial
Enthalten in Nature medicine 29.9.2025: 1-8
|
|
|
|
143 |
A double-blind, placebo-controlled investigation of the acute effects of Essence ring aromatherapy on sleep using actigraphy
Enthalten in Sleep and biological rhythms 26.9.2025: 1-10
|
|
|
|
144 |
Dupilumab Versus Mepolizumab for COPD: Evaluating Efficacy Outcomes Using Placebo-Adjusted Indirect Treatment Comparison
Enthalten in Pulmonary therapy 26.9.2025: 1-17
|
|
|
|
145 |
Acute effects of MDMA, MDA, lysine-MDMA, and lysine-MDA in a randomized, double-blind, placebo-controlled, crossover trial in healthy participants
Enthalten in Neuropsychopharmacology 25.9.2025: 1-10
|
|
|
|
146 |
Gut microbiota and exercise: A systematic review of interventions and evidence limitations
Enthalten in International journal of sports medicine 18.09.2025
|
|
|
|
147 |
Effect of Nicotinamide Adenine Dinucleotide on Heart Failure Caused by Ischemic Cardiomyopathy: A Randomized, Placebo-Controlled Trial
Enthalten in American journal of cardiovascular drugs 15.9.2025: 1-10
|
|
|
|
148 |
The Efficacy of Oral Melatonin in Abdominal Aortic Aneurysm Surgery
Enthalten in The international journal of angiology 08.09.2025
|
|
|
|
149 |
The proBNPage reduction (PBAR) trial—results of a randomized, double blind, placebo-controlled, pilot study to fine tune an NT-proBNP-based method to assess the effect of anti-aging treatments
Enthalten in GeroScience 8.9.2025: 1-17
|
|
|
|
150 |
Safety and pharmacokinetics evaluation of oroxylin A in Chinese healthy volunteers: a phase I, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect study
Enthalten in Clinical and translational oncology 3.9.2025: 1-14
|
|
Administration
